Can RFID Take Us Beyond DSCSA to Stop Counterfeits, Improve Safety, and Streamline Pharma Operations? Are We Doing Enough?

As the FDA implemented a stabilization period for a group of dispensers in 2023, the Drug Supply Chain Security Act (DSCSA) is now officially in effect. The pharmaceutical industry is under increasing pressure to ensure product authenticity, traceability, and patient safety. But is compliance enough? In this webinar, we’ll explore how Radio Frequency Identification (RFID) technology can go beyond DSCSA mandates to address persistent challenges in the pharmaceutical supply chain—including counterfeit prevention, operational inefficiencies, and real-time visibility. What You’ll Learn: * The current state of DSCSA—and what’s next * How RFID can be integrated into enterprise systems and scaled across operations * Lessons from real-world RFID pilot implementations * Strategic advantages for manufacturers, wholesalers & pharmacies This session will highlight a recent RFID pilot study conducted by The Axia Institute at Michigan State University with key industry stakeholders and offer insights into how RFID can be integrated into enterprise systems, scaled across operations, and potentially adopted by wholesalers, pharmacies, and beyond. Panelists from the Axia Institute, CCL/eAgile and Cencora will share technical perspectives, industry implications, and strategic takeaways that point to RFID as a transformative tool—not just for compliance, but for unlocking broader business and safety benefits.